316 related articles for article (PubMed ID: 35491730)
1. Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis.
Wang X; Liang N; Tian T; Zhang J; Hu P
Technol Cancer Res Treat; 2022; 21():15330338221089937. PubMed ID: 35491730
[No Abstract] [Full Text] [Related]
2. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
Wei J; Jiang Y; Shao Z
Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy after mastectomy has significant survival benefits for inflammatory breast cancer: a SEER population-based retrospective study.
Li ZW; Zhang M; Yang YJ; Zhou ZJ; Liu YL; Li H; Bao B; Diao JD; Wang DW
PeerJ; 2020; 8():e8512. PubMed ID: 32117621
[TBL] [Abstract][Full Text] [Related]
4. [Effect of postmastectomy radiotherapy on survival outcomes of patients with metaplastic breast cancer].
Cai W; Zhuang Y; Chen J; Wang H
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov; 41(11):1733-1740. PubMed ID: 34916202
[TBL] [Abstract][Full Text] [Related]
5. Postmastectomy radiation therapy in T3 node-negative breast cancer.
Elmore L; Deshpande A; Daly M; Margenthaler JA
J Surg Res; 2015 Nov; 199(1):90-6. PubMed ID: 25976852
[TBL] [Abstract][Full Text] [Related]
6. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers.
Francis SR; Frandsen J; Kokeny KE; Gaffney DK; Poppe MM
Breast; 2017 Apr; 32():156-161. PubMed ID: 28193571
[TBL] [Abstract][Full Text] [Related]
8. Impact of postmastectomy radiotherapy in T3N0 invasive carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis.
McCammon R; Finlayson C; Schwer A; Rabinovitch R
Cancer; 2008 Aug; 113(4):683-9. PubMed ID: 18543316
[TBL] [Abstract][Full Text] [Related]
9. The trade-off of post-mastectomy radiotherapy usage for the breast cancer patients aged 70 years or older: a study based on SEER database.
Lin J; Luo S; Zhang J; Song C
BMC Geriatr; 2023 Oct; 23(1):625. PubMed ID: 37803254
[TBL] [Abstract][Full Text] [Related]
10. Postmastectomy radiation therapy for T3N0: a SEER analysis.
Johnson ME; Handorf EA; Martin JM; Hayes SB
Cancer; 2014 Nov; 120(22):3569-74. PubMed ID: 24985911
[TBL] [Abstract][Full Text] [Related]
11. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
12. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.
Liu J; Mao K; Jiang S; Jiang W; Chen K; Kim BY; Liu Q; Jacobs LK
Oncotarget; 2016 Apr; 7(17):24848-59. PubMed ID: 26709538
[TBL] [Abstract][Full Text] [Related]
13. Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis.
Abrams MJ; Koffer PP; Wazer DE; Hepel JT
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):384-391. PubMed ID: 28463158
[TBL] [Abstract][Full Text] [Related]
14. The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancer.
Yang T; Zhong X; Wang J; Xiang Z; Zeng Y; Yu S; Dai Z; Xu N; Luo T; Liu L
Cancer Med; 2023 Apr; 12(7):8112-8121. PubMed ID: 36734308
[TBL] [Abstract][Full Text] [Related]
15. Effects of postmastectomy radiotherapy on survival in different age groups for patients with T3N0M0 breast cancer.
He MT; Lu XX; Gou ZC
Breast; 2021 Dec; 60():247-254. PubMed ID: 34808436
[TBL] [Abstract][Full Text] [Related]
16. A prognostic score model to determine which breast cancer patients with 1-3 positive lymph nodes after modified radical mastectomy should receive radiotherapy.
Chen D; Wang H; Song X; Shi F; Kong L; Yu J
Oncotarget; 2018 Jan; 9(1):385-393. PubMed ID: 29416621
[TBL] [Abstract][Full Text] [Related]
17. The effect of post mastectomy radiation therapy on survival in breast cancer patients with N1mic disease.
Patel M; Li C; Aronson JH; Howie CM; Maraboyina S; Prabhu AV; Kim T
Breast; 2020 Jun; 51():50-56. PubMed ID: 32213441
[TBL] [Abstract][Full Text] [Related]
18. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
[TBL] [Abstract][Full Text] [Related]
19. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit of radiotherapy after surgery in de novo stage IV breast cancer: a population-based propensity-score matched analysis.
Kim YJ; Jung SY; Kim K
Sci Rep; 2019 Jun; 9(1):8527. PubMed ID: 31189932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
